Asimov
Synthetic Biology
2 open roles Synthetic Biology Boston, United States 122 employees $234M raised Est. 2017
Andreessen Horowitz
Horizons Ventures
CPP Investments
Fidelity Management & Research Company
KdT Ventures
Casdin Capital
About Asimov
Asimov builds tools to program living cells, aiming to unlock the full potential of synthetic biology.
Asimov is listed on Rocketlist with 2 active roles. The company is categorized as Synthetic Biology in BioTech. Asimov is at Series B stage, with a B2B business model, headquartered in Boston, United States. Asimov was founded in 2017 and has 122 employees. Asimov has raised $234M. Active roles are refreshed daily from public hiring sources.